Peptide Research Stacks
Curated peptide combinations used in research protocols — with dosing, timing and goals for each. No human clinical trials exist for most combinations. For research purposes only.
Research purposes only. These are reference protocols, not medical advice. No human clinical trials exist for most combinations. Always follow applicable regulations in your jurisdiction.
Research Stacks
Select a stack based on your research goal. Each combines peptides for synergistic effect. Dosing, frequency, and duration are provided as reference — modify based on your protocol and response.
GH Pulse Stack
Peptides
Protocol
2–3× daily, subcutaneous, before fasted cardio or sleep
The most studied GH secretagogue combination. CJC-1295 extends Ipamorelin's GH pulse.
Recovery & Repair Stack
Peptides
Protocol
BPC-157 1–2× daily SC; TB-500 2× weekly (loading phase 4 weeks, then 1× weekly)
No human clinical trials exist — all dosing extrapolated. Most widely researched combo for connective tissue repair.
GLP-1 Weight Loss Stack
Peptides
Protocol
1× weekly SC, escalate by 2.5 mg every 4 weeks to tolerance
Single-agent protocol. GIP + GLP-1 dual agonist. Based on SURMOUNT-1 trial escalation protocol.
Aggressive GH Stack
Peptides
Protocol
2–3× daily SC, fasted
Higher ghrelin stimulation than Ipamorelin. Stronger hunger side effects. For experienced researchers.
Longevity Anti-Aging Stack
Peptides
Protocol
Ipamorelin 2× daily; Epithalon 1× daily for 10-day cycle, 2× per year
Combines GH pulse support with telomere-related Epithalon protocols from Khavinson's research.
Cognitive Focus Stack
Peptides
Protocol
1–2× daily intranasal or SC
Russian clinical peptides often used together: Semax for focus/BDNF, Selank for anxiety reduction.
Immune Support Stack
Peptides
Protocol
2× weekly SC for 6–12 weeks
FDA Orphan Drug designation. Well-established fixed 1.6 mg dose protocol.
Semaglutide Weight Loss Stack
Peptides
Protocol
1× weekly SC, escalate every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg
STEP trial fixed escalation. Most studied GLP-1 agonist for weight management.
Frequently Asked Questions
Understanding peptide stacking principles and safety.
What is a peptide research stack?
A peptide stack is a combination of two or more peptides designed to work synergistically. Stacking allows researchers to target multiple pathways simultaneously — for example, combining a GH-releasing peptide (Ipamorelin) with a GHRH analog (CJC-1295) to amplify GH pulse amplitude and duration beyond either peptide alone.
Are these stacks proven in humans?
Most stacks shown here have limited or no human clinical trial data. Dosing and protocols are extrapolated from animal studies, observational reports, and practitioner consensus. Individual peptides have varying levels of human evidence: Semaglutide and Tirzepatide have robust Phase 3 trial data (STEP, SURMOUNT). BPC-157 and TB-500 have only animal data. Always consult current research and local regulations.
How do I choose which stack to try?
Choose based on your research goal. GH stacks (GH Pulse, Aggressive GH, Longevity) target growth hormone secretion. Recovery stacks (Recovery & Repair) target tissue healing. Weight loss stacks (GLP-1, Semaglutide) target appetite and metabolism. Cognitive stacks target BDNF and mood. Start with lower doses, monitor response, and adjust over 4–8 weeks.
Can I modify these stacks or combine peptides differently?
Yes. These are reference protocols, not prescriptions. You can adjust doses, frequencies, and durations based on response and literature. Synergistic peptides work well together — GH secretagogues + GHRH analogs, recovery peptides + antiinflammatories, GLP-1 agents + lifestyle. Test one variable at a time to identify what works for your protocol.
Research Tools
Complete your research workflow.